Multiplex allele-specific polymerase chain reaction for detection of isoniazid resistance in Mycobacterium tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 6, 2011, Pages

  Tho, D Q ^a   Lan, N T N ^b   Chau, N V V ^c   Farrar, J ^a,d   Caws, Maxine ^a,d  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b Pham Ngoc Thach Hospital   (Viet Nam)

^c Hospital of Tropical Diseases   (Viet Nam)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Isoniazid; Polymerase chain reaction; Resistance; Tuberculosis

Indexed keywords

ISONIAZID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; GENE IDENTIFICATION; GOLD STANDARD; INHA 15 GENE; INTERMETHOD COMPARISON; KATG315 GENE; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 79955862158     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0599     Document Type: Article

References (29)

1. World Health Organization. WHO report 2009. Global TB control: epidemiology, strategy, financing. WHO/HTM/TB/2009. 411. Geneva, Switzerland: WHO, 2009.
2. World Health Organization. WHO report 2006. Global TB control: surveillance, planning, financing. WHO/HTM/TB/2006. 362. Geneva, Switzerland: WHO, 2006.
3. World Health Organization. Treatment of tuberculosis: guidelines. 4th edition, 2009. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009.
4. World Health Organization. Report of the second meeting of the WHO Task Force on XDR-TB. 9-10 April 2008. WHO/ HTM/TB/2008.403. Geneva, Switzerland: WHO, 2008.
5. Mitnick C D, Shin S S, Seung K J, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-574.
6. Boehme C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
7. Pai M, Kalantri S, Pascopella L, Riley L W, Reingold A L. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 2005; 51: 175-187. (Pubitemid 41554824)
8. Quy H T, Cobelens F G, Lan N T, Buu T N, Lambregts C S, Borgdorff M W. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10: 45-51. (Pubitemid 43266276)
9. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/IUATLD Global Project on Drug Resistance Surveillance. WHO/CDS/TB/2003.320. Geneva, Switzerland: WHO, 2003.
10. Baker L V, Brown T J, Maxwell O, et al. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism. Antimicrob Agents Chemother 2005; 49: 1455-1464.
11. Cardoso R F, Cooksey R C, Morlock G P, et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother 2004; 48: 3373-3381. (Pubitemid 39129333)
12. Guo H, Seet Q, Denkin S, Parsons L, Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol 2006; 55 (Pt 11): 1527-1531. (Pubitemid 44713868)
13. Marttila H J, Soini H, Huovinen P, Viljanen M K. katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother 1996; 40: 2187-2189. (Pubitemid 26296270)
14. Silva M S, Senna S G, Ribeiro M O, et al. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 4471-4474. (Pubitemid 37099736)
15. Hazbon M H, Brimacombe M, Bobadilla del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006; 50: 2640-2649. (Pubitemid 44198682)
16. Caws M, Duy P M, Tho D Q, Lan N T, Hoa D V, Farrar J. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 2006; 44: 2333-2337. (Pubitemid 44092394)
17. Mokrousov I, Otten T, Filipenko M, et al. Detection of i soniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. J Clin Microbiol 2002; 40: 2509-2512. (Pubitemid 34747356)
18. Herrera-Leon L, Molina T, Saiz P, Saez-Nieto J A, Jimenez M S. New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 2005; 49: 144-147. (Pubitemid 40065785)
19. Garcia de Viedma D, del Sol Diaz Infantes M, Lasala F, Chaves F, Alcala L, Bouza E. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 988-995. (Pubitemid 34208657)
20. Caws M, Tho D Q, Duy P M, et al. PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1789-1793. (Pubitemid 46933908)
21. Honore-Bouakline S, Vincensini J P, Giacuzzo V, Lagrange P H, Herrmann J L. Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol 2003; 41: 2323-2329. (Pubitemid 36712431)
22. Telenti A, Honore N, Bernasconi C, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997; 35: 719-723. (Pubitemid 27083868)
23. Silva M S N, Senna S G, Ribeiro M O, et al. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 4471-4474. (Pubitemid 37099736)
24. Tho D Q, Ha D T, Duy P M, et al. Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2008; 12: 1306-1312.
25. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman M E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177: 787-792. (Pubitemid 351490566)
26. Foundation for Innovative New Diagnostics. FIND prices for GenoType® MTBDRplus and country list. Geneva, Switzerland: FIND. http://www. finddiagnostics.org/programs/find-negotiated- prices/mtbdrplus.html Accessed September 2010.
27. Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med 2009; 6: e1000146.
28. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, UK: National Collaborating Centre for Chronic Conditions, Royal College of Physicians, 2006. http://guidance.nice.org.uk/CG33/ Guidance/pdf/English Accessed September 2010.
29. American Thoracic Society, CDC and Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52 (RR-11): 1-77.